Covadonga Alonso MD PhD is Professor of research at Consejo Superior de Investigaciones Científicas,Dpt. Biotechnology of INIA, Madrid, Spain. Her group is interested in finding new targets for antivirals against highly pathogenic viruses from a One Health perspective. We focus in finding common targets for SARS-CoV-2, Ebola, and African swine fever virus, based on host-pathogen interactions and innate immunity studies. Our working model has been African swine fever virus (ASFV) in which we have identified cellular molecules that are crucial for viral infection at several levels, including viral entry/uncoating and transport, replication, autophagy, and lipid regulation. This agent causes an acute deadly infection in domestic pigs with a high socio-economic impact in Europe and Asia nowadays. Our goal is to increase knowledge on the mechanisms required for infection in order to find targets for new vaccination and antiviral strategies. I have been Chair of Asfarviridae study group of the ICTV, CEO of the Global African swine fever Research Alliance (GARA) and acting Vicepresident of the Board of the Spanish Society for Virology, between others.